Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic

doi:10.21203/rs.3.rs-161008/v1

Download PDF

Research Article

Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic

https://doi.org/10.21203/rs.3.rs-161008/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Background The COVID-19 pandemic has had a disruptive effect on people with haematological cancers, who represent a high-risk population due to the nature of their disease and immunosuppressive treatments. We aimed to identify the psychological impacts of the COVID-19 pandemic on haematology patients and identify correlated factors to inform the development of appropriate supportive interventions.

Methods 394 respondents volunteered their participation in response to a study advertisement distributed online through established haematology groups. Participants completed a self-report online survey exploring well-being, psychological distress, unmet supportive care needs, and fear of cancer recurrence.

Results At least 1 in 3 respondents (35%) reported clinical levels of distress and nearly 1 in 3 (32%) identified at least one unmet need. Among respondents in remission (n = 134), clinical fear of cancer recurrence was reported by nearly all (95%). Unmet needs, pre-existing health conditions, younger age, financial concerns, and perceived risk of contracting COVID-19 were the dominant factors contributing to psychological distress during the pandemic. Psychological distress, lost income, perceived inadequate support from care team, perceived risk of contracting COVID-19, and being a woman were significantly associated with unmet needs. Psychological distress and concern about the impact of COVID-19 on cancer management were significantly associated with fear of cancer recurrence among respondents in remission.

Conclusion Results highlight the high psychological burden and unmet needs experienced by people with haematological cancers during the COVID-19 pandemic and indicate a need for innovative solutions to rapidly identify distress and unmet needs during, and beyond, pandemic times.

Oncology

Infectious Diseases

Health Economics & Outcomes Research

haematology patients

psychological distress

supportive care

psychooncology

COVID-19 pandemic

The COVID-19 pandemic has presented many challenges for those with cancer, with members of this population subgroup at increased risk of contracting COVID-19 and experiencing severe complications or death from the virus [1]. Due to these vulnerabilities, powerful health messages have stressed the higher risk posed to cancer patients and many cancer treatments have been modified or delayed to minimise patients’ exposure to COVID-19 [2]. Although these changes to usual care were designed to protect vulnerable cancer patients in the short-term, evidence is beginning to emerge of the potential long-term consequences of these actions. For example, fear of infection has resulted in many patients making their own choice to delay care, with a study conducted by the American College of Emergency Physicians during the first wave of the COVID-19 pandemic finding that 29% of the cancer patients surveyed reported they had avoided visiting the emergency department due to fears of contracting the virus [3]. In Australia, the context of the present study, cancer hospitals reported a 40% decline in patient presentations for cancer management appointments during the pandemic [4], similar to reductions reported in other countries [5, 6]. These figures are concerning given recently published research indicates that delaying curative treatment by just one month increases cancer patients’ risk of death by as much as 10% [7].

The psychological effects of limiting cancer care during the COVID-19 pandemic are likely to be significant. Community-based cancer organisations have reported an increase in the number of calls to their support lines, with many patients reporting anxiety about their risk of contracting COVID-19 [8]. Mitigating these psychological effects has thus become a health priority [9–11]. Research examining the psychological impact of the pandemic can help to inform the development of appropriate interventions, yet there is a lack of such research on people with haematological cancers. This is concerning given those with a haematological cancer represent a particularly vulnerable subgroup of cancer patients due to (i) the nature of their disease (i.e., damage to the immune system) and (ii) immunosuppressive treatments such as haematopoietic stem cell transplantation (HSCT), which places patients at increased risk of respiratory viral infections [12, 13].

In addition to the risks associated with contracting COVID-19, the pandemic has severely impacted the availability of donor stem cell products for haematological cancer patients who are planned to undergo HSCT. Finding a suitable stem cell donor is challenging and there may not be a suitable donor identified in the same country as the recipient. In Australia, over 80% of donated stem cells come from international volunteer donors [14]. Rapid border closures and flight changes have limited the availability of stem cell products, creating significant challenges for those who were planned to undergo potentially life-saving HSCT [15–17].

There are legitimate concerns about the emergence of a range of negative psychological consequences of the COVID-19 pandemic among people with haematological cancers. To inform the development of appropriate support interventions that actively mitigate the psychological consequences of the pandemic and future pandemics among haematological patients, the present study investigated (i) the prevalence of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the pandemic and (ii) correlates of these psychological factors.

Respondents

Eligible respondents were adults aged ≥18 years who currently have, or previously have had, a confirmed diagnosis of haematological cancer and had sufficient English language skills to participate without an interpreter.

Recruitment

Respondents volunteered their participation in response to a study advertisement distributed via email and/or social media platforms by established national community groups (Leukaemia Foundation), professional member societies and working groups (Victorian COVID-19 Cancer Network), and clinical trial groups (Australasian Leukaemia & Lymphoma Group). Potential respondents were provided a link to an online information sheet, consent form, and survey. The study protocol was approved by the University of Melbourne Human Research Ethics Committee (Ref: 2057125.1).

Measures

An online cross-sectional survey was conducted from 22 July to 19 August 2020 and was used to collect the following information.

Demographic characteristics: Data on age, gender, postcode, marital status, education level, employment status, and number of dependants living in the home during the COVID-19 pandemic were collected. Residential postcode was used to classify respondents’ location (Major cities/Inner regional/Outer regional/Remote/Very remote) as per the Australian Bureau of Statistics Australian Statistical Geography Standard (ASGS) [18].

Medical characteristics: Information regarding respondents’ primary diagnosis, date of diagnosis, treatment, disease status, pre-existing health conditions, and type of hospital managing respondents’ care was collected.

Cancer care experience: Four questions were designed by the research team to better understand the care experiences of respondents during the pandemic (see Table 1). Questions explored opportunities for family support, access to care, perceived adequacy of access to support, and ability to maintain contact with the health care team.

Financial concerns: Two items were designed to explore respondents’ financial wellbeing during the pandemic, including whether they had lost income due to lockdown measures (Table 1).

Perceived risk and impact of COVID-19 on cancer management: Five questions were designed to investigate respondents’ concerns about the impact of COVID-19 on their own health and their perceived risk of contracting COVID-19 (Table 1).

Psychological distress: Psychological distress was measured using the Kessler 10-item assessment (K10) [19]. Respondents indicated the extent to which they experienced each emotional state since the beginning of the pandemic using a 5-point Likert scale ranging from 1 (“None of the time”) to 5 (“All the time”). Cronbach’s alpha in this sample was 0.92, indicating a high level of internal consistency. Scores were divided into three categories representing mild (range 20-24), moderate (range 25-29), and severe psychological distress (range 30-50).

Unmet supportive care needs: Respondents’ perceived needs during COVID-19 were captured by the subdomains Health system and Information needs (11 items) and Patient care and Support needs (5 items) of the short-form Supportive Care Needs Survey (SCNS-SF34) [20]. The SCNS-SF34 had excellent internal consistency in this specific sample (Cronbach's α = 0.97). The SCNS-SF34 uses a 5-point scale to measure unmet need: 1 = No need – not applicable, 2 = No need – satisfied, 3 = Low need, 4 = Moderate need, and 5 = High need. In line with previous research [20], responses 1 and 2 were re-coded as 0 (“No need”) and subsequent categories were re-scored accordingly 1 (“Low need”), 2 (“Moderate need”), and 3 (“High need”).

Fear of cancer recurrence (FCR): Respondents who had completed treatment and were in remission were asked to complete the 9-item Severity subscale of the Fear of Cancer Recurrence Inventory (FCRI) [21]. This subscale evaluates the severity of intrusive thoughts associated with respondents’ fears about the possibility that cancer could return or progress on a 5-point Likert scale ranging from 1 (“Not at all”) to 5 (“A great deal”). The accepted cut-off score for clinical FCR is 13. The FCRI had acceptable internal consistency in this sample (Cronbach's α = 0.77).

Data analysis

Survey data were collected in Qualtrics and de-identified prior to being exported to SPSS (V26.0, IBM SPSS) for analysis. Descriptive statistics (e.g., frequencies, means, and standard deviations) were calculated. Univariate linear regressions were conducted to identify potential correlates of psychological distress, unmet supportive care needs, and FCR. All variables significant at p < 0.05 were subsequently included in multiple linear regression models to determine their relative contribution to each of the dependent variables. Moderation analyses were carried out to further identify high risk groups and explored the effects of gender (1 = men, 2 = women), location (1 = major cities, 2 = regional), age (treated as continuous), marital status (1 = single, 2 = married/defacto), education (1 = < tertiary, 2 = tertiary), and employment status (1 = employed, 2 = unemployed).

Respondent characteristics

A total of 394 respondents aged 16 to 84 years (mean ± standard deviation (SD): 60.4 years ± 12.8) participated in this study (See Online Resource 1 for the sample characteristics table). Respondents were evenly divided between major cities (50%) and regional areas (50%). The ratio of men (53%) to women (47%) was relatively even and most were married (71%). Lymphoma (34%) and leukaemia (27%) were the most common haematological cancers reported. Over half (53%) of all respondents had received a haematological cancer diagnosis within the previous three years. In terms of stage of treatment, 43% were currently receiving ongoing, or maintenance treatment while 37% were in remission.

Psychological distress, unmet supportive care needs, and fear of cancer recurrence

Descriptive statistics for the dependent variables of psychological distress, unmet supportive care needs, and FCR are presented in Table 2. Thirty-five percent of respondents (n = 138) had elevated scores on the Kessler Psychological Distress scale, with 17% reporting scores suggestive of mild distress, 8% reporting scores suggestive of moderate distress, and 9% reporting scores suggestive of severe distress. Overall, 32% (n = 128) of respondents reported experiencing at least one unmet moderate or high need; 28% reported at least one unmet moderate or high need in the Health system and Information domain and 24% reported at least one unmet moderate or high need in the Patient care and Support domain. The most prevalent unmet needs were (i) having access to professional counselling (15%), (ii) being given information about test results as soon as feasible (15%), and (iii) being treated like a person (15%). Of those who had completed treatment and were in remission (n = 134), all respondents reported some degree of FCR, with 95% reporting clinical FCR.

Financial concerns

In terms of financial wellbeing during the pandemic, 26% of respondents had lost income and 29% indicated their financial concerns had been worse compared to the period before the outbreak.

Perceived risk and impact of COVID-19 on cancer management

Regarding the perceived adequacy of measures used to prevent transmission of COVID-19 in hospitals, 61% of respondents expressed some degree of concern (32% ‘a little bit concerned’, 15% ‘moderately concerned’, 8% ‘quite concerned’, 6% ‘very concerned’). Regarding their concerns about access of hospital staff to protective equipment to prevent COVID-19 transmission, 62% of respondents reported some degree of concern (29% ‘a little bit concerned’, 13% ‘moderately concerned’, 9% ‘quite concerned’, 11% ‘very concerned’). When asked how concerned they were about the impact of COVID-19 on their cancer management, 70% respondents reported some degree of concern (33% ‘a little bit concerned’, 19% ‘moderately concerned’, 12% ‘quite concerned’, 6% ‘very concerned’).

Cancer care experience

During the COVID-19 pandemic, 35% of respondents indicated they had limited opportunity for family support, and 21% had been restricted in accessing care due to travel bans. Regarding their care team, the majority of respondents felt they had maintained good contact (80%) and received adequate support (71%).

Factors associated with psychological distress

Online Resource 2 presents the factors found in univariate regression analyses to be significantly associated with psychological distress during the pandemic. These factors were entered simultaneously in a multiple regression model (adjusted R² = .37, F(11, 324) = 18.63, p < .001; Table 3). Six of the factors remained significant, collectively explaining 35% of the variance in psychological distress. Specifically, unmet needs, pre-existing health conditions, younger age, financial concerns, perceived risk of contracting COVID-19, and living in a regional area were associated with greater psychological distress during the pandemic.

Moderation analyses revealed that (i) age moderated the relationship between financial concerns and psychological distress (B = 0.09, 95% CI = 0.03, 0.16, t = 2.72, p = .007), such that the association between financial concerns and distress was stronger in younger people compared to older people, and (ii) marital status moderated the relationship between perceived risk of contracting COVID-19 and higher psychological distress (B = -0.55, 95% CI = -0.91, -0.18, t = -2.94, p = .004), such that the association between perceived risk of COVID-19 and distress was higher among those who were single compared to those who were married.

Factors associated with unmet supportive care needs

Online Resource 2 presents the factors found in univariate analyses to be significantly associated with unmet supportive care needs during the COVID-19 pandemic. These factors were entered simultaneously into a multiple regression model (adjusted R² = .22, F(8, 331) = 12.89, p < .001; Table 3). Five of the factors remained significant, collectively explaining 22% of the variance in unmet supportive care needs. Psychological distress, lost income, perceived inadequate support from care team, perceived risk of contracting COVID-19, and being a woman were found to be significantly associated with greater unmet supportive care needs during the pandemic.

Moderation analyses revealed that (i) gender moderated the relationship between psychological distress and unmet needs (B = 0.45, 95% CI = 0.18, 0.73, t = 3.25, p = .001), such that the association between psychological distress and unmet needs was stronger in women than in men, and (ii) age moderated the relationship between lost income and unmet needs (B = -0.05, 95% CI = -0.09, -0.00, t = -2.06, p = .039), such that the association between lost income and unmet needs was stronger in younger people compared to older people.

Factors associated with fear of cancer recurrence

Online Resource 2 presents the factors found in univariate analyses to be significantly associated with higher FCR during the COVID-19 pandemic among respondents in remission. These factors were entered simultaneously into a multiple regression model (adjusted R² = .29, F(5, 120) = 11.21, p < .001; Table 3). Two of the factors remained significant, collectively explaining 28% of variance in FCR. Specifically, psychological distress and concern about the impact of COVID-19 on cancer management were associated with greater FCR during the pandemic. No significant moderators were identified.

This study aimed to identify the psychological issues experienced during the COVID-19 pandemic by haematological cancer patients and to identify correlated factors to inform the development of appropriate interventions. In this cross-sectional study we found a high prevalence of psychological distress and unmet supportive care needs, which was much higher than results obtained from two previous studies involving Australian haematology patients during non-pandemic times [22, 23]. Developing innovative solutions to screen for distress and unmet needs and responding to these needs in a timely manner is crucial, especially during pandemic times when face-to-face clinical care is limited.

FCR was particularly prominent among respondents in the present study, with nearly all (95%) of those in remission reporting clinical levels of FCR. While FCR is arguably one of the most common issues among cancer survivors, the prevalence among this sample is significantly higher than that previously seen in survivors of solid cancers and haematological cancers in non-pandemic times [24, 25]. Given FCR is associated with high rates of depression and greater health care utilisation [26] and does not appear to abate over time [27], haematological cancer patients may benefit from (i) greater validation of their concerns and (ii) enhanced routine screening to determine the severity of FCR and the need for specialised treatment of FCR. A single-item screening instrument has recently been developed for this purpose [28]. Due to its brevity, the tool can easily be used in clinical follow-ups and may be better suited to the time and resource constraints of health professionals, many of whom are managing additional workload demands as results of the pandemic.

Unmet needs emerged as a key contributor to psychological distress among those surveyed in the present study. These findings are in line with previous research reporting positive associations between unmet needs and psychological morbidity among haematological cancer patients [29]. The widespread disruptions to accessing cancer care services during the pandemic may explain why ‘having access to professional counselling’, ‘being given information about test results as soon as feasible’, and ‘being treated like a person’ were the three highest ranked needs in this study. Moreover, the pandemic has likely heightened these needs due to travel restrictions posing additional barriers to accessing care, which was a concern reported by at least one in five (21%) respondents in this study. Our results suggest that attending to these needs among haematological cancer patients constitutes a potential means of reducing psychological distress.

Our results highlight the increased financial hardship faced by haematology patients during the COVID-19 pandemic. At least one in four respondents indicated they had lost income as a result of the pandemic and had increased financial concerns. Lost income was associated with greater unmet needs, while financial concerns were associated with greater psychological distress. These associations underscore existing literature suggesting financial stress is a relatively powerful predictor of distress among haematological cancer patients, who are particularly vulnerable to these difficulties due to the expensive and prolonged nature of treatments such as HSCT that can lead to extended time away from work [30, 29, 31]. This study also found that the associations between (i) financial concerns and psychological distress and (ii) lost income and unmet needs were stronger in younger people compared to older people, indicating that this subgroup of patients may benefit most from additional support in accessing financial assistance. Validated screening tools, such as the 11-item COST-FACIT [32], may assist clinicians with identifying those patients at high risk who may benefit from additional financial advocacy resources and referral to targeted interventions.

This study found evidence of positive associations between perceived risk of contracting COVID-19 and both psychological distress and unmet needs, with the association between perceived risk and distress stronger among single persons. Additionally, a positive association was observed between concern about the impact of COVID-19 on cancer management and FCR among respondents in remission. In Australia, messages communicating the dangers of COVID-19 have led to unintended declines in patient presentations for cancer management appointments [4]. Several community-based cancer organisations have already taken proactive steps to help restore the delivery of cancer care through social media campaign initiatives. For example, the “Don’t delay” and “Here for you” campaigns encourage patients to follow-up on health concerns and access cancer support [33, 34]. Our results suggest this messaging should reassure patients about the safety of clinical facilities and inform them of the availability and effectiveness of telehealth appointments [35]. This may help to reduce fears of contracting COVID-19 and restore much needed cancer care.

Building upon previous research [36], the present study found higher levels of distress amongst regional compared to urban respondents. In recent years, there have been increased efforts to enable access to cancer services for regional haematological cancer patients, since much of their needed care is only offered in urban treatment centres [37]. However, unwarranted variation in care for regional patients is an issue that continues to demand action, which has likely heightened during the pandemic due to travel restrictions posing additional barriers to accessing care.

Several study limitations need to be considered. First, an eligibility requirement that respondents have sufficient English language skills is likely to have prevented the participation of individuals from culturally and linguistically diverse (CALD) backgrounds. Future research considering the needs of these individuals is critical. This is particularly important given the rapid uptake of telehealth consultations, which are less suited to CALD patients and may exacerbate inequalities that are already apparent in cancer care [14, 36]. Second, the present findings should be interpreted with caution due to the potential for bias resulting from our self-selection recruitment method. Third, as this study was cross-sectional, causative links cannot be assumed and require further investigation in prospective studies. Finally, this study did not include detailed questions about patients’ perspectives or experiences resulting from receiving care via telehealth. A qualitative study examining the perceived value of telehealth during the COVID-19 pandemic is currently ongoing.

The present study appears to be one of the first to explore the prevalence and correlates of psychological distress, unmet needs, and FCR in haematological cancer patients during the COVID-19 pandemic. Results indicated that respondents experience high levels of distress and unmet needs, and that the majority in remission experience clinical FCR. These findings highlight the need for supportive interventions to assist haematological cancer patients to better manage distress, unmet needs, and FCR, which is particularly important during pandemic times when face-to-face clinical care is limited. The correlated factors identified in this study can be used to inform the development of appropriate support interventions and target those most in need, including financial concerns, lost income, younger age, living in a regional area, perceived risk of contracting COVID-19, and concern about the impact of COVID-19 on the management of haematological cancers. It is hoped that the present findings encourage much-needed efforts to minimise major disruptions to cancer care and mitigate the longer-term psychological impact on people with haematological cancers.

Funding: This work was supported by a private donation made to the Melbourne School of Psychological Sciences to support research into the impact of COVID-19 on cancer patients.

Conflict of interest: The authors declare that they have no conflict of interest in this work.

Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Melbourne Human Research Ethics Committee (Ref: 2057125.1) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate: Informed consent was obtained from all individual participants included in the study.

Consent for publication: Participants provided informed consent regarding publishing their data.

Data availability: The data that support the findings of this study are available upon request from the corresponding author.

Code availability: N/A

Author contributions: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Nienke Zomerdijk, Michelle Jongenelis, and Camille E. Short. The first draft of the manuscript was written by Nienke Zomerdijk and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR et al (2020) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. The Lancet 395(10241):1907–1918. doi:10.1016/S0140-6736(20)31187-9
Weinkove R, McQuilten Z, Adler J, Agar M, Blyth E, Cheng A et al (2020) Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. The Medical Journal of Australia 212(10):481–489. doi:10.5694/mja2.50607
American College of Emergency Physicians. COVID-19 (2020) https://www.emergencyphysicians.org/globalassets/emphysicians/all-pdfs/acep-mc-COVID19-april-poll-analysis.pdf. Accessed 28 November 2020
Monash Partners Comprehensive Cancer Consortium. Victoria launches safe cancer care campaign for patients (2020) https://www.monashpartnersccc.org/news/victoria-launches-safe-cancer-care-campaign-for-patients. Accessed 6 May 2020
Dinmohamed AG, Visser O, Verhoeven RH, Louwman MW, van Nederveen FH, Willems SM et al (2020) Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. The Lancet Oncology 21(6):750–751. doi:10.1016/S1470-2045(20)30265-5
Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R et al (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. The Lancet Oncology 21(8):1023–1034. doi:10.1016/S1470-2045(20)30388-0
Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E et al (2020) Mortality due to cancer treatment delay: systematic review and meta-analysis. The British Medical Journal 371:m4087. doi:10.1136/bmj.m4087
World Ovarian Cancer Coalition, World Pancreatic Cancer Coalition, Lymphoma Coalition, Advanced Breast Cancer Global Alliance, Coalitions WBCP. The Impact of COVID-19 on Cancer Patient Organisations 2020. https://worldovariancancercoalition.org/wp-content/uploads/2020/06/The-impact-of-COVID-19-on-Cancer-Patient-Organisations-12th-June-2020-FINAL.pdf. Accessed 11 November 2020
Chen G, Wu Q, Jiang H, Zhang H, Peng J, Hu J et al. Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19. Psycho-oncology. 2020(29):1395–1398. doi:10.1002/pon.5451
Ng DW, Chan FH, Barry TJ, Lam C, Chong CY, Kok HC et al (2020) Psychological distress during the 2019 Coronavirus Disease (COVID-19) pandemic among cancer survivors and healthy controls. Psycho-oncology 29(9):1380–1383. doi:10.1002/pon.5437
Swainston J, Chapman B, Grunfeld EA, Derakshan N. COVID-19 lockdown and its adverse impact on psychological health in breast cancer. Frontiers in psychology. 2020;11. doi:10.3389/fpsyg.2020.02033
Eichenberger EM, Soave R, Zappetti D, Small CB, Shore T, van Besien K et al (2019) Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients. Bone marrow transplantation 54(7):1058–1066. doi:10.1038/s41409-018-0386-z
Lee LY, Cazier J-B, Starkey T, Briggs SE, Arnold R, Bisht V et al (2020) COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. The Lancet Oncology 21(10):1309–1316. doi:10.1016/S1470-2045(20)30442-3
Leukaemia Foundation. National Strategic Action Plan for Blood Cancer (2020) https://www.leukaemia.org.au/national-action-plan. Accessed 19 November 2020
Purtill J (2020) Graham is waiting on lifesaving stem cell treatment. Coronavirus is stopping delivery. Australian Broadcasting Company. https://www.abc.net.au/triplej/programs/hack/stem-cell-transplants-coronavirus/12070468. Accessed 6 May 2020
Mengling T, Rall G, Bernas SN, Astreou N, Bochert S, Boelk T et al (2020) Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS. Bone Marrow Transplant. doi:10.1038/s41409-020-01138-0
Lloyd M (2020) Australia scrambles to save blood cancer patients as COVID-19 border closures delay foreign cell transplants. ABC News. https://www.abc.net.au/news/2020-09-24/covid-19-border-closure-forces-stem-cell-transplant-workaround/12688108. Accessed 23 November 2020
Australian Bureau of Statistics. Australian Standard Geographical Classification (ASGC) Volume 5 Remoteness Structure. ABS, Canberra (2016) http://www.abs.gov.au. Accessed 4 September 2020
Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E et al (2003) Screening for serious mental illness in the general population. Arch Gen Psychiatry 60(2):184–189
Boyes A, Girgis A, Lecathelinais C (2009) Brief assessment of adult cancer patients' perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS‐SF34). Journal of evaluation in clinical practice 15(4):602–606. doi:10.1111/j.1365-2753.2008.01057.x
Simard S, Savard J (2009) Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Supportive care in cancer 17(3):241–251. doi:10.1007/s00520-008-0444-y
Hall AE, Sanson-Fisher RW, Carey ML, Paul C, Williamson A, Bradstock K et al (2016) Prevalence and associates of psychological distress in haematological cancer survivors. Support Care Cancer 24(10):4413–4422. doi:10.1007/s00520-016-3282-3
Boyes AW, Clinton-McHarg T, Waller AE, Steele A, D’Este CA, Sanson-Fisher RW (2015) Prevalence and correlates of the unmet supportive care needs of individuals diagnosed with a haematological malignancy. Acta Oncol 54(4):507–514. doi:10.3109/0284186x.2014.958527
Thewes B, Butow P, Bell ML, Beith J, Stuart-Harris R, Grossi M et al (2012) Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer 20(11):2651–2659. doi:10.1007/s00520-011-1371-x
Borreani C, Alfieri S, Farina L, Bianchi E, Corradini P (2020) Fear of cancer recurrence in haematological cancer patients: exploring socio-demographic, psychological, existential and disease-related factors. Support Care Cancer 28(12):5973–5982. doi:10.1007/s00520-020-05434-9
Mutsaers B, Jones G, Rutkowski N, Tomei C, Leclair CS, Petricone-Westwood D et al (2016) When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Supportive care in cancer 24(10):4207–4218. doi:10.1007/s00520-016-3248-5
Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300–322. doi:10.1007/s11764-013-0272-z
Rudy L, Maheu C, Körner A, Lebel S, Gélinas C (2020) The FCR-1: Initial validation of a single‐item measure of fear of cancer recurrence. Psycho‐Oncology 29(4):788–795. doi:10.1002/pon.5350
Tzelepis F, Paul CL, Sanson-Fisher RW, Campbell HS, Bradstock K, Carey ML et al (2018) Unmet supportive care needs of haematological cancer survivors: rural versus urban residents. Annals of hematology 97(7):1283–1292. doi:10.1007/s00277-018-3285-x
Hamilton JG, Wu LM, Austin JE, Valdimarsdottir H, Basmajian K, Vu A et al (2013) Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psycho‐Oncology 22(4):911–921. doi:10.1002/pon.3091
Majhail NS, Rizzo JD, Hahn T, Lee SJ, McCarthy PL, Ammi M et al (2013) Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Bone marrow transplantation 48(6):865–871. doi:10.1038/bmt.2012.248
De Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D et al (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120(20):3245–3253
Cancer Council Victoria. Don't Delay Campaign Resources (2020) https://www.cancervic.org.au/get-support/covid-19/dont-delay/assets.html. Accessed 17 November 2020
United Kingdom National Health Service. Don’t delay seeing a GP if you have signs and symptoms of cancer (2020) https://www.leedsccg.nhs.uk/news/dont-delay-seeing-a-gp-if-you-have-signs-and-symptoms-of-cancer. Accessed 17 November 2020
Sansom-Daly UM, Wakefield CE, McGill BC, Wilson HL, Patterson P (2016) Consensus among international ethical guidelines for the provision of videoconferencing-based mental health treatments. JMIR Mental Health 3(2):e17. doi:10.2196/mental.5481
Royal Australian College of General Practitioners. Fears for culturally and linguistically diverse patients avoiding healthcare due to COVID-19. 2020. https://www.racgp.org.au/gp-news/media-releases/2020-media-releases/july-2020/fears-for-culturally-and-linguistically-diverse-pa. Accessed 2020 1 December

Download PDF

Editorial decision: Major Revisions Needed
20 Apr, 2021
Reviews received at journal
08 Mar, 2021
Reviewers invited by journal
23 Feb, 2021
First submitted to journal
21 Jan, 2021

You are reading this latest preprint version

Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic

Status:

Version 1

Abstract

Introduction

Methods

Results

Discussion

Limitations

Conclusion

Declarations

References

Supplementary Files

Status:

Version 1